Neuland Laboratories Ltd. benchmarking: Perfomance to industry peers

Financial

	Neuland Laboratories	Gufic Biosciences	Alivus Life Sciences
Operational Metrics
Pharmaceuticals
US DMF Filings	73.0 .	n/a	586.0 .
Global DMFs filed	995.0 .	n/a	n/a
Total reactor capacity	1174.0 kL	n/a	n/a
R&D as a % of Total Sales	4.15 %	1.28 %	3.6 %
Financials
5 yr Average ROE	14.95 %	16.89 %	25.27 %
5yr average Equity Multiplier	1.56	2.16	1.74
5yr Average Asset Turnover Ratio	0.74	0.75	0.71
5yr Avg Net Profit Margin	13.18 %	10.24 %	20.19 %
Price to Book	13.44	5.59	3.55
P/E	90.67	61.99	20.21
5yr Avg Cash Conversion Cycle	38.21 Days	-15.25 Days	100.66 Days
Inventory Days	87.5 Days	71.73 Days	95.06 Days
Days Receivable	85.17 Days	106.89 Days	132.12 Days
Days Payable	118.14 Days	179.29 Days	120.47 Days
5yr Average Interest Coverage Ratio	20.78	8.9	371.82
5yr Avg ROCE	17.63 %	17.89 %	33.88 %
5yr Avg Operating Profit Margin	21.01 %	18.12 %	29.64 %
5 yr average Debt to Equity	0.15	0.67	0.0
5yr CAGR Net Profit	26.4 %	-2.66 %	6.67 %
5yr Average Return on Assets	9.87 %	7.7 %	14.28 %
Shareholdings
Promoter Holding	32.64 %	72.5 %	74.91 %
Share Pledged by Promoters	0.0	0.0	0.0
Change in Promoter Holding (3 Yrs)	-3.58 %	-2.5 %	-7.94 %
Change in Mutual Fund Holding (3 Yrs)	8.99 %	2.45 %	3.16 %

Business

	Neuland Laboratories	Gufic Biosciences	Alivus Life Sciences
Product Wise Break-Up	Product Wise Break-Up Formulations 71.0 Custom Manufacturing Solutions(CMS) 26.0 API 0 Muscle Relaxants 0 Cardiovascular 0 Proton pump inhibitors 0 Anti-fungals 0 Anti-bacterials 0 International 0 CMO 0 Domestic 0 API`s 0 CDMO 0 Generic API 0 Others 3.0	Product Wise Break-Up CMO 30.0 Generic API 0 Anti-fungals 0 Proton pump inhibitors 0 Anti-bacterials 0 Muscle Relaxants 0 API`s 0 Cardiovascular 0 International 15.0 CDMO 0 Formulations 0 Domestic Pharmaceuticals 50.0 Custom Manufacturing Solutions(CMS) 0 Active Pharmaceutical Ingredient (API) 5.0	Product Wise Break-Up CMO 0 Generic API 92.93 Anti-fungals 0 Proton pump inhibitors 0 Anti-bacterials 0 Muscle Relaxants 0 API`s 0 Cardiovascular 0 International 0 CDMO 4.73 Formulations 0 Domestic 0 Custom Manufacturing Solutions(CMS) 0 API 0 Others 2.34
Location Wise Break-Up	Location Wise Break-Up India 30.39 Europe 29.86 USA 29.35 Rest of the World 10.4 South America 0 Australia 0 North America 0 Asia 0 Africa 0	Location Wise Break-Up Australia 0.08 Rest of the World 0 India 79.83 Africa 2.95 North America 1.19 South America 2.37 USA 0 Europe 7.54 Asia Pacific 6.04	Location Wise Break-Up Australia 0 Rest of the World 0 India 48.28 Africa 0 North America 0 South America 0 USA 0 Europe 0 Asia 0 Others 51.72
Therapeutic Area Break-Up	Therapeutic Area Break-Up Anti-bacterial 19.72 Antidepressant 11.8 Anticonvulsant 10.46 Pain Management 0 Diabetes 0 CNS 0 CVS 0 Others 58.02	-	Therapeutic Area Break-Up Anticonvulsant 0 CNS 14.0 CVS 42.0 Anti-bacterial 0 Diabetes 4.0 Pain Management 4.0 Antidepressant 0 Others 36.0
Asset Break-Up	Asset Break-Up India 100.0	-	-

Neuland Laboratories Ltd.

Neuland Laboratories Ltd.

Financial

Business

SIGN UP FOR FREE